Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Reduction of inflammatory reaction in the use of purified alginate microcapsules.

Kim AR, Hwang JH, Kim HM, Kim HN, Song JE, Yang YI, Yoon KH, Lee D, Khang G.

J Biomater Sci Polym Ed. 2013;24(9):1084-98. doi: 10.1080/09205063.2012.735100. Epub 2012 Nov 22.

PMID:
23683040
2.

Effects of purified alginate sponge on the regeneration of chondrocytes: in vitro and in vivo.

Song JE, Kim AR, Lee CJ, Tripathy N, Yoon KH, Lee D, Khang G.

J Biomater Sci Polym Ed. 2015;26(3):181-95. doi: 10.1080/09205063.2014.987570. Epub 2014 Dec 11.

PMID:
25495827
3.

Direct effect of alginate purification on the survival of islets immobilized in alginate-based microcapsules.

Langlois G, Dusseault J, Bilodeau S, Tam SK, Magassouba D, Hallé JP.

Acta Biomater. 2009 Nov;5(9):3433-40. doi: 10.1016/j.actbio.2009.05.029. Epub 2009 Jun 9.

PMID:
19520193
4.

Inflammatory response to peritoneal implantation of alginate-poly-L-lysine microcapsules.

Robitaille R, Dusseault J, Henley N, Desbiens K, Labrecque N, Hallé JP.

Biomaterials. 2005 Jul;26(19):4119-27.

PMID:
15664639
5.

The role of pathogen-associated molecular patterns in inflammatory responses against alginate based microcapsules.

Paredes-Juarez GA, de Haan BJ, Faas MM, de Vos P.

J Control Release. 2013 Dec 28;172(3):983-92. doi: 10.1016/j.jconrel.2013.09.009. Epub 2013 Sep 17.

PMID:
24051034
6.

Comparison of two types of alginate microcapsules on stability and biocompatibility in vitro and in vivo.

Li HB, Jiang H, Wang CY, Duan CM, Ye Y, Su XP, Kong QX, Wu JF, Guo XM.

Biomed Mater. 2006 Mar;1(1):42-7. doi: 10.1088/1748-6041/1/1/007. Epub 2006 Mar 15.

PMID:
18458385
7.

[Effect of alginate purity on microencapsulated hepatocyte overgrowth in peritoneal transplantation].

Yu C, Leng X, Wei Y, Liu J, Du R.

Zhonghua Wai Ke Za Zhi. 2000 Apr;38(4):300-2, 19. Chinese.

PMID:
12828177
8.

Biocompatibility of mannuronic acid-rich alginates.

Klöck G, Pfeffermann A, Ryser C, Gröhn P, Kuttler B, Hahn HJ, Zimmermann U.

Biomaterials. 1997 May;18(10):707-13.

PMID:
9158852
9.

Self-cross-linking biopolymers as injectable in situ forming biodegradable scaffolds.

Balakrishnan B, Jayakrishnan A.

Biomaterials. 2005 Jun;26(18):3941-51.

PMID:
15626441
10.

Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets.

De Vos P, De Haan BJ, Wolters GH, Strubbe JH, Van Schilfgaarde R.

Diabetologia. 1997 Mar;40(3):262-70.

PMID:
9084963
11.

Formulating the alginate-polyornithine biocapsule for prolonged stability: evaluation of composition and manufacturing technique.

Thanos CG, Calafiore R, Basta G, Bintz BE, Bell WJ, Hudak J, Vasconcellos A, Schneider P, Skinner SJ, Geaney M, Tan P, Elliot RB, Tatnell M, Escobar L, Qian H, Mathiowitz E, Emerich DF.

J Biomed Mater Res A. 2007 Oct;83(1):216-24.

PMID:
17607741
12.

Effect of prolonged gelling time on the intrinsic properties of barium alginate microcapsules and its biocompatibility.

Vaithilingam V, Kollarikova G, Qi M, Lacik I, Oberholzer J, Guillemin GJ, Tuch BE.

J Microencapsul. 2011;28(6):499-507. doi: 10.3109/02652048.2011.586067.

PMID:
21827357
13.

Biocompatibility and membrane strength of C3H10T1/2 cell-loaded alginate-based microcapsules.

Zhang WJ, Li BG, Zhang C, Xie XH, Tang TT.

Cytotherapy. 2008;10(1):90-7. doi: 10.1080/14653240701762372.

PMID:
18202978
14.

Alginate modification improves long-term survival and function of transplanted encapsulated islets.

Mallett AG, Korbutt GS.

Tissue Eng Part A. 2009 Jun;15(6):1301-9. doi: 10.1089/ten.tea.2008.0118.

PMID:
18950258
15.

Transplantation of alginate microcapsules: generation of antibodies against alginates and encapsulated porcine islet-like cell clusters.

Kulseng B, Skjåk-Braek G, Ryan L, Andersson A, King A, Faxvaag A, Espevik T.

Transplantation. 1999 Apr 15;67(7):978-84.

PMID:
10221481
16.

Calcium alginate microcapsules with spherical liquid cores templated by gelatin microparticles for mass production of multicellular spheroids.

Sakai S, Ito S, Kawakami K.

Acta Biomater. 2010 Aug;6(8):3132-7. doi: 10.1016/j.actbio.2010.02.003. Epub 2010 Feb 8.

PMID:
20144915
17.

In vitro and in vivo evaluation of anti-inflammatory agents using nanoengineered alginate carriers: towards localized implant inflammation suppression.

Jayant RD, McShane MJ, Srivastava R.

Int J Pharm. 2011 Jan 17;403(1-2):268-75. doi: 10.1016/j.ijpharm.2010.10.035. Epub 2010 Nov 2.

PMID:
21050881
18.
19.

Survival of different cell lines in alginate-agarose microcapsules.

Orive G, Hernández RM, Gascón AR, Igartua M, Pedraz JL.

Eur J Pharm Sci. 2003 Jan;18(1):23-30.

PMID:
12554069
20.

Alginate microcapsules prepared with xyloglucan as a synthetic extracellular matrix for hepatocyte attachment.

Seo SJ, Akaike T, Choi YJ, Shirakawa M, Kang IK, Cho CS.

Biomaterials. 2005 Jun;26(17):3607-15.

PMID:
15621251

Supplemental Content

Support Center